These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23331120)

  • 1. Comments on Waldeyer et al. 'Response to Hex et al. Estimating the current and future costs for Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs'.
    Hex N; Taylor M; Bartlett C
    Diabet Med; 2013 Apr; 30(4):503-4. PubMed ID: 23331120
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to Hex et al. Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs.
    Waldeyer R; Brinks R; Giani G
    Diabet Med; 2013 Apr; 30(4):502-3. PubMed ID: 23126636
    [No Abstract]   [Full Text] [Related]  

  • 3. Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs.
    Hex N; Bartlett C; Wright D; Taylor M; Varley D
    Diabet Med; 2012 Jul; 29(7):855-62. PubMed ID: 22537247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of economic effects of population ageing--methodology of estimating indirect costs.
    Schubert A; Czech M; Gębska-Kuczerowska A
    Przegl Epidemiol; 2015; 69(3):529-35, 637-42. PubMed ID: 26519851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare resource use, direct and indirect costs of hypoglycemia in type 1 and type 2 diabetes, and nationwide projections. Results of the HYPOS-1 study.
    Giorda CB; Rossi MC; Ozzello O; Gentile S; Aglialoro A; Chiambretti A; Baccetti F; Gentile FM; Romeo F; Lucisano G; Nicolucci A;
    Nutr Metab Cardiovasc Dis; 2017 Mar; 27(3):209-216. PubMed ID: 28017523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The direct medical cost of type 2 diabetes mellitus in South Africa: a cost of illness study.
    Erzse A; Stacey N; Chola L; Tugendhaft A; Freeman M; Hofman K
    Glob Health Action; 2019; 12(1):1636611. PubMed ID: 31282315
    [No Abstract]   [Full Text] [Related]  

  • 7. The costs of type 2 diabetes mellitus outpatient care in the Brazilian public health system.
    Bahia LR; Araujo DV; Schaan BD; Dib SA; Negrato CA; Leão MP; Ramos AJ; Forti AC; Gomes MB; Foss MC; Monteiro RA; Sartorelli D; Franco LJ
    Value Health; 2011; 14(5 Suppl 1):S137-40. PubMed ID: 21839888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost-effectiveness of intensive therapy for diabetes mellitus.
    Herman WH; Dasbach EJ; Songer TJ; Eastman RC
    Endocrinol Metab Clin North Am; 1997 Sep; 26(3):679-95. PubMed ID: 9314022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The economic burden of nephropathy in diabetic patients in Germany in 2002.
    Happich M; Landgraf R; Piehlmeier W; Falkenstein P; Stamenitis S
    Diabetes Res Clin Pract; 2008 Apr; 80(1):34-9. PubMed ID: 18187227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic impact of severe and non-severe hypoglycemia in patients with Type 1 and Type 2 diabetes in the United States.
    Foos V; Varol N; Curtis BH; Boye KS; Grant D; Palmer JL; McEwan P
    J Med Econ; 2015 Jun; 18(6):420-32. PubMed ID: 25629654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A cost of illness study of diabetes mellitus].
    von Ferber L; Köster I; Hauner H
    Gesundheitswesen; 1997 Jan; 59(1):17-22. PubMed ID: 9138642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the burden of diabetes in Poland].
    Kissimova-Skarbek K; Pach D; Płaczkiewicz E; Szurkowska M; Szybiński Z
    Pol Arch Med Wewn; 2001 Sep; 106(3):867-73. PubMed ID: 11928598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A total cost perspective of type 1 and 2 diabetes mellitus in two South African medical schemes servicing the public healthcare sector.
    Opperman AM; De Klerk M
    S Afr Med J; 2021 Jun; 111(7):635-641. PubMed ID: 34382546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intractable spastic cerebral palsy in children: a Dutch cost of illness study.
    Hoving MA; Evers SM; Ament AJ; van Raak EP; Vles JS;
    Dev Med Child Neurol; 2007 May; 49(5):397-8. PubMed ID: 17503555
    [No Abstract]   [Full Text] [Related]  

  • 15. [Resources for prevention?].
    MMW Fortschr Med; 2006 Dec; 148(51-52):62-3. PubMed ID: 17619351
    [No Abstract]   [Full Text] [Related]  

  • 16. Current and future economic burden of diabetes among working-age adults in Asia: conservative estimates for Singapore from 2010-2050.
    Png ME; Yoong J; Phan TP; Wee HL
    BMC Public Health; 2016 Feb; 16():153. PubMed ID: 26880337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical resource use, disturbance of daily life and burden of hypoglycemia in insulin-treated patients with diabetes: results from a European online survey.
    Willis WD; Diago-Cabezudo JI; Madec-Hily A; Aslam A
    Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):123-30. PubMed ID: 23402452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economics of type 2 diabetes prevention.
    Kissimova-Skarbek K
    Przegl Lek; 2006; 63 Suppl 4():9-11. PubMed ID: 16967708
    [No Abstract]   [Full Text] [Related]  

  • 19. Sex differences in healthcare expenditures among adults with diabetes: evidence from the medical expenditure panel survey, 2002-2011.
    Williams JS; Bishu K; Dismuke CE; Egede LE
    BMC Health Serv Res; 2017 Apr; 17(1):259. PubMed ID: 28399859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The outpatient cost of diabetes care in Italian diabetes centers.
    Garattini L; Tediosi F; Chiaffarino F; Roggeri D; Parazzini F; Coscelli C;
    Value Health; 2001; 4(3):251-7. PubMed ID: 11705186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.